Zantac and Bacitracin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zantac (ranitidine hydrochloride) and Bacitracin (bacitracin). Common drug interactions include pneumonia among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Zantac and Bacitracin. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Zantac?

Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 434,161 Zantac users. Check the latest studies of Zantac.

What is Bacitracin?

Bacitracin has active ingredients of bacitracin. eHealthMe is studying from 1,214 Bacitracin users. Check the latest studies of Bacitracin.



On Aug, 02, 2026

32 people who take Zantac and Bacitracin together, and have interactions are studied.

Zantac and Bacitracin drug interactions.

What are the common drug interactions of Zantac and Bacitracin, by gender? *:

female:

  1. Pneumonia
  2. Pyrexia (fever)
  3. Rash
  4. Rectal haemorrhage (bleeding from anus)
  5. Renal failure (kidney dysfunction)
  6. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  7. Abscess (pus)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Aseptic necrosis bone

male:

  1. Abdominal pain
  2. Constipation
  3. Infection
  4. Medical device complication
  5. Renal papillary necrosis (a disorder of the kidneys in which all or part of the renal papillae die)
  6. Rigors (an episode of shaking or exaggerated shivering)
  7. Tinnitus (a ringing in the ears)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Urinary retention (the inability to completely or partially empty the bladder)
  10. Weakness

What are the common drug interactions of Zantac and Bacitracin, by age (0-1 to 60+)? *:

0-1:

  1. Agitation (state of anxiety or nervous excitement)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Bradycardia (abnormally slow heart action)
  4. Cardiac murmur (an heart sound in valve abnormality)
  5. Hydronephrosis (water inside the kidney)
  6. Pyrexia (fever)
  7. Ureteric dilatation
  8. Ureteric obstruction
  9. Vomiting

2-9:

n/a

10-19:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

20-29:

  1. Vomiting
  2. Diarrhoea
  3. Pyrexia (fever)
  4. Abdominal pain
  5. Acute circulatory failure (shock)
  6. C-reactive protein increased
  7. Constipation
  8. Dehydration (dryness resulting from the removal of water)
  9. Dyspnoea (difficult or laboured respiration)
  10. Empyema (collection of pus in a cavity in the body)

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Cough
  4. Dyspnoea (difficult or laboured respiration)
  5. Hypoacusis (loss of hearing)
  6. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  7. Joint stiffness
  8. Neuralgia (pain in one or more nerves)
  9. Pruritus (severe itching of the skin)
  10. Rash

50-59:

  1. Dry mouth
  2. Failure to thrive (inadequate weight gain and physical growth in children)
  3. Fatigue (feeling of tiredness)
  4. General physical health deterioration (weak health status)
  5. Hypotension (abnormally low blood pressure)
  6. Insomnia (sleeplessness)
  7. Medical device complication
  8. Pain in limb
  9. Panic disorder
  10. Paraplegia (paralysis of the legs and lower body)

60+:

  1. Anaemia (lack of blood)
  2. Weight decreased
  3. Anxiety
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Back pain
  6. Chronic kidney disease
  7. Depression
  8. Disturbance in attention
  9. Fall
  10. Haemorrhage (bleeding)

What are the existing conditions these people have? *

  1. Infection: 4 people, 12.50%
  2. Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 9.38%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 9.38%
  4. Pain: 2 people, 6.25%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.25%
  6. Itching: 2 people, 6.25%
  7. Hypersensitivity: 2 people, 6.25%
  8. High Blood Pressure: 2 people, 6.25%
  9. High Blood Cholesterol: 2 people, 6.25%
  10. Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Zantac and Bacitracin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zantac and Bacitracin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zantac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bacitracin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zantac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bacitracin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride and bacitracin (the active ingredients of Zantac and Bacitracin, respectively), and Zantac and Bacitracin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: